BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 27314324)

  • 1. Toxicological Considerations, Toxicity Assessment, and Risk Management of Inhaled Nanoparticles.
    Bakand S; Hayes A
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physio-pathological impacts of inhaled nanoparticles].
    Baeza-Squiban A
    Biol Aujourdhui; 2014; 208(2):151-8. PubMed ID: 25190574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles: a review of particle toxicology following inhalation exposure.
    Bakand S; Hayes A; Dechsakulthorn F
    Inhal Toxicol; 2012; 24(2):125-35. PubMed ID: 22260506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the toxicity of selected types of nanochemicals.
    Kumar V; Kumari A; Guleria P; Yadav SK
    Rev Environ Contam Toxicol; 2012; 215():39-121. PubMed ID: 22057930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles toxicity and their routes of exposures.
    Yah CS; Simate GS; Iyuke SE
    Pak J Pharm Sci; 2012 Apr; 25(2):477-91. PubMed ID: 22459480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface engineering of inorganic nanoparticles for imaging and therapy.
    Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
    Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge to relate the physicochemical properties of colloidal nanoparticles to their cytotoxicity.
    Rivera-Gil P; Jimenez de Aberasturi D; Wulf V; Pelaz B; del Pino P; Zhao Y; de la Fuente JM; Ruiz de Larramendi I; Rojo T; Liang XJ; Parak WJ
    Acc Chem Res; 2013 Mar; 46(3):743-9. PubMed ID: 22786674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the effects of manufactured nanoparticles on mammalian target organs.
    Wu T; Tang M
    J Appl Toxicol; 2018 Jan; 38(1):25-40. PubMed ID: 28799656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicological perspectives of inhaled therapeutics and nanoparticles.
    Hayes AJ; Bakand S
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):933-47. PubMed ID: 24810077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake and bio-reactivity of polystyrene nanoparticles is affected by surface modifications, ageing and LPS adsorption: in vitro studies on neural tissue cells.
    Murali K; Kenesei K; Li Y; Demeter K; Környei Z; Madarász E
    Nanoscale; 2015 Mar; 7(9):4199-210. PubMed ID: 25673096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential adverse effects of nanoparticles on the reproductive system.
    Wang R; Song B; Wu J; Zhang Y; Chen A; Shao L
    Int J Nanomedicine; 2018; 13():8487-8506. PubMed ID: 30587973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabricated nanoparticles: current status and potential phytotoxic threats.
    Yadav T; Mungray AA; Mungray AK
    Rev Environ Contam Toxicol; 2014; 230():83-110. PubMed ID: 24609519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to using mechanism-based structure activity relationship (SAR) analysis to assess human health hazard potential of nanomaterials.
    Lai DY
    Food Chem Toxicol; 2015 Nov; 85():120-6. PubMed ID: 26111809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of nanomaterials in vivo: blood circulation and organ clearance.
    Wang B; He X; Zhang Z; Zhao Y; Feng W
    Acc Chem Res; 2013 Mar; 46(3):761-9. PubMed ID: 23964655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotoxicological impact of occupational and environmental nanoparticles exposure: The influence of physical, chemical, and combined characteristics of the particles.
    Pedata P; Petrarca C; Garzillo EM; Di Gioacchino M
    Int J Immunopathol Pharmacol; 2016 Sep; 29(3):343-53. PubMed ID: 26684639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species.
    Carlson C; Hussain SM; Schrand AM; Braydich-Stolle LK; Hess KL; Jones RL; Schlager JJ
    J Phys Chem B; 2008 Oct; 112(43):13608-19. PubMed ID: 18831567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles and the brain: cause for concern?
    Oberdörster G; Elder A; Rinderknecht A
    J Nanosci Nanotechnol; 2009 Aug; 9(8):4996-5007. PubMed ID: 19928180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications.
    Johnston H; Brown D; Kermanizadeh A; Gubbins E; Stone V
    J Control Release; 2012 Dec; 164(3):307-13. PubMed ID: 22940205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding nanoparticle cellular entry: A physicochemical perspective.
    Beddoes CM; Case CP; Briscoe WH
    Adv Colloid Interface Sci; 2015 Apr; 218():48-68. PubMed ID: 25708746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and Cellular Toxicology of Nanomaterials with Related to Aquatic Organisms.
    Rather MA; Bhat IA; Sharma N; Sharma R
    Adv Exp Med Biol; 2018; 1048():263-284. PubMed ID: 29453544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.